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We evaluated the Olympus Demand as a cost-saving measure, as a
back up to a Technicon SMAC I, and to be the primary instrument
for enzyme analysis. In general, it wasfound to be precise, reliable,
easy to operate, but with only average turn-around time capabili-
ties. Technically there were several limitations: (1) significant
bilirubin interference in the analysis of serum bicarbonate and
creatinine; (2) instability ofthe ion selective electrodes; (3) lengthy
routine maintenance requiredfor the ion selective electrode module;
(4) serum phosphorus and uric acid methods required blanking due
to interferencefrom bilirubin, hemolysis, or lipemia; and (5) serum
triglyceride analysis included measurement offree glycerol.
The Olympus Demand model AU 500 (Cooper Biomed-
ical Inc., Malvern, Pennsylvania 19355, USA) was
selected for evaluation from among several chemistry
discrete analysers available on the market. The instru-
ment which is a fully automated random access analyser,
is capable ofhandling up to 100 samples for 23 chemistry
tests at any given time. It comprises an analytical and a
control console, both of which are connected by a
communication cable, permitting some flexibility in their
arrangement. The maximum throughput is 400 tests per
hour, which can be increased if sodium, potassium, and
chloride are included.
A primary goal ofthe evaluation was to achieve improved
cost effectiveness by replacing the use of one of two
Technicon SMAC Is (Technicon Instruments Corpora-
tion, Tarrytown, New York 10591, USA) and provide
back up for the remaining SMAC I. Improved cost
effectiveness could be obtained by decreasing technolo-
gist time, cost of reagents (discrete testing versus
continuous flow), and numerous repeat analysis due to
channel malfunction. Two limited evaluations of the
Demand have since confirmed cost effectiveness of the
instrument [1 and 2]. Another major goal of the
evaluation was to investigate an alternative instrument
for measurement of enzyme activities.
Materials and methods
Instrument operation
The Demand uses equilibrium, kinetic, and ion selective
electrodes for measurement methods. Equilibrium
methods are based on single point calibration which is
stable for 24 h with the exception of bicarbonate which
must be recalibrated every 4 h. Kinetic measurements are
based on preprogrammed molar absorptivity values. If
substrate depletion occurs, it is detected and indicated by
the instrument. Ion selective electrodes (ISE) use two-
point internal calibration with an optional external
calibrator. The ISE calibrates automatically every 30
min and in addition calibrates whenever a run ofsamples
includes a sodium, potassium or chloride measurement.
The analytical console contains a refrigerated reagent
turntable, fluids metering system, sampler, cuvette
loader, cuvette turntable, bichromatic photometric
measuring system (10 wavelengths available), and the
ISE module. All temperatures are automatically con-
trolled and an alarm system is present to detect any
deviation. The control console, which commands the
analytical unit, consists of a data processor unit (DPU),
cathode ray tube (CRT), keyboard, and printer. The
Demand has bidirectional computer capabilities but
requires an interface board in the DPU, appropriate
software for the host computer, and an Apple IIe personal
computer (Apple Computer, Cupertino, California
95014, USA).
The control console is used to program tests to be
performed on each sample and the capacity for program-
ming is 100 samples excluding calibrators and controls.
Once the analyses is completed on a sample, that sample
’position’ is again available for programming of tests
requested for a new sample.
The Demand uses a variety of colour-coded sample cup
carriers to contain patient specimens, controls, or calibra-
tors. As the sample carrier chain is advanced to the
sample probe area, the carrier type and position are read.
This information is matched with the previously
programmed tests requested and directs the loading of
the correct number of cuvettes, sample volumes and
reagent volumes. The plastic disposable cuvettes are
loaded onto the 72-position turntable every 9 s as it
rotates and all samples and reagents are diluted with
prewarmed deionized water and mechanically mixed.
Before the sample is added, a set of absorbance readings
is taken which serve as a reagent blank. After the sample
is added, a set of absorbances is read at the primary and
secondary wavelengths followed by a second set of
absorbances taken at a later photometer. This informa-
tion is transmitted to the DPU; and when all analyses are
completed, the results are printed. Also, the instrument
has the capability of printing absorbance units.
Daily and weekly maintenance is minimal, partly due to
the fact that the sample and two reagent probes are
washed internally and externally after each use. The ISE
module requires more time for maintenance, especially
the weekly procedure.
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Table 1. Manufacturer’s recommended methods, reagent volumes, and sample volumes for the Olympus Demand.
Sample
Primary/second volume
Test Method wavelength (1)
Reagent
volume
(l)
Sodium
Potassium Ion selective electrodes Not applicable 50
Bicarbonate Phosphoenolpyruvate carboxylase 380/410 7
equilibrium
Glucose Hexokinase-UV equilibrium 340/380 5
Creatinine Jaffe- kinetic 520/570 25
BUN Urease- kinetic 340/380 10
Total protein Biuret- equilibrium 540/660 10
Albumin Bromcresol green equilibrium 600/540 5
Inorganic Ammonium molybdate-UV equilibrium 340/380 10
phosphorus
Total bilirubin Diazotized sulphanilic acid equilibrium 540/600 15 Blank
15-Test
Conjugated Diazotized sulphanilic acid- equilibrium 540/600 15 Blank
bilirubin 15 Test
ALP p-Nitrophenylphosphate- kinetic 410/480 7
AST Oxaloacetate/NADH-UV kinetic 340/380 15
ALT Pyruvate/NADH-UV kinetic 340/380 25
LD Lactate/NAD+ UV kinetic 340/380 10
CK Glucose-6-phosphate/NADP+-UV kinetic 340/380. 15
Cholesterol Cholesterol esterase/oxidate- equilibrium 540/600 5
Triglyceride Tetrazolium chloride/NADH ’- equilibrium 520/600 5
Uric acid Uricase/quinonemine dye-equilibrium 540/600 20
20
70
100
40
60
100
100
100
60- Blank
60-Test
60- Blank
60-Test
100
50
30
50
50
100
50
60
Reagents and calibrators
The tests evaluated in our laboratory using Cooper
Biomedical reagents were sodium, potassium, chloride,
bicarbonate, glucose, creatinine, BUN (blood urea nit-
rogen), total protein, albumin, inorganic phosphorus,
total bilirubin, conjugated (direct) bilirubin, ALP, ASP,
ALT, LD, CK, cholesterol, trigylceride, and uric acid*.
All analyses were carried out at 37C in accordance with
manufacturer’s instructions [3]. Table provides a
summary of methods, sample volumes, and reagent
volumes. The instrument can be operated with user-
defined methods [4].
Initially, the Cooper Biomedical protein based calibrator,
Flozyme, was used for all tests except conjugated
bilirubin and the ISE. Beckman Direct Bilirubin Calibra-
tor Number 7 (Beckman Instruments, Inc., Brea, Califor-
nia 92621, USA) was used for the conjugated bilirubin
and the ISE were calibrated with two levels of internal
calibrators. Due to the low concentration of total
bilirubin in Flozyme, a change was made to Omega
Chemistry Control Serum-Elevated Bilirubin (Cooper
Biomedical, Inc, Malvern, Pennsylvania 19355, USA) for
the total bilirubin calibrator. All calibration material
* Non-standard abbreviations: ALP, alkaline phosphatase (EC
3.1.3.1); AST, aspartate aminotransferase (EC 2.6.1.1); ALT,
alanine aminotransferase (EC 2.6.1.2); CK, creatine kinase (EC
2.7.3.2); LD, lactate dehydrogenase (EC 1.1.1.27).
114
concentrations were verified with primary standards
where possible.
To assess photometric precision, a solution of potassium
dichromate (4"2 g/l) was prepared and analysed on the
instrument at wavelengths 380/410 nm comparing the
first photometer with the other 14 photometers. With-in
run and between-run precision studies were performed
using a combination ofthree different control materials at
various concentrations. The control materials were
Omega Assayed Control Serum I and II, Omega
Chemistry Control Serum-Elevated Bilirubin, and Tech-
nicon TQC Chemistry Control L and H (Technicon
Instruments Corporation, Tarrytown, New York 10951,
USA).
To study carry-over of the sample dispenser, two glucose
solutions containing 4"0 mmol/1 and 31"6 mmol/1 were
prepared. These solutions were analysed alternatively (N
20) and percentage carry-over determined [5].
Linearity was evaluated using primary aqueous stan-
dards prepared in our laboratory for sodium, chloride,
bicarbonate, glucose, BUN, inorganic phosphorus, and
uric acid. For potassium and creatinine the Linearity
Multi-Point Standard Set (American Scientific Products,
McGaw Park, Illinois 60085, USA) was used. Two
specially prepared albumin-based materials from Clin-
ical Chemistry Consultants (Temple City, California
9180, USA) were obtained to test the linearity ofALP,
AST, ALT, LD, CK, and cholesterol. Protein Standard
Solution (Sigma Chemical Company, St. Louis, Minne-
sota 618, USA) was utilized for the total protein andS. B. Schotters et al. Evaluation of the Olympus Demand analyser
Normal Serum Albumin (Human) 25% (Cutter Biolog-
ical, Berkeley, California 94710, USA) was used for
albumin linearity. Crystalline bilirubin (Sigma Chemical
Co., St. Louis, Minnesota 63178, USA) was used for total
bilirubin and pooled patient serum was employed for
conjugated bilirubin linearity evaluation. For the linear-
ity testing of triglyceride, a patient body fluid with a
concentration of greater than 28"2 mmol/l was utilized.
Each linearity study was performed with no less than five
levels of concentration; each level analysed in triplicate,
and a mean value determined.
For the correlation study we used patient sera that had
been analysed on the same day on SMAC I. All
specimens were kept covered to minimize evaporation
between assays.
The effect of bilirubin, hemolysis, and lipemia on all
analytes was investigated. For bilirubin, selected serum
samples containing a wide concentration range of each
analyte were spiked with crystalline bilirubin at a
concentration of 171 mol/1 dissolved in a normal pooled
serum. Aliquots ofthe same selected samples were spiked
with three levels ofconcentration ofhemoglobin 500"0 g/l,
2500"0 g/l, and 5000"0 g/1 for the hemolysis study. In both
of these an aliquot of the nonspiked serum sample was
diluted appropriately to compensate for the dilutional
effects of the spiking. For the lipemia study serum
samples were selected which visually had slight (1 +) to
gross lipemia (4+) present. These samples were analysed
before and after ultracentrifugation in a Beckman Airfuge
(Beckman Instruments, Inc., Brea, California 92621).
Results
Precision
Within-run precision (N 14) of the 14 photometers
resulted in a CV of 1"0%. Within-run precision (N
20) was performed on all tests using three different
control materials at various concentrations. The
between-run precision studies were performed using the
same control materials over a period of 20 days. Table 2
shows both the within-run and between-run precision
results of all analytes. BUN was the only analyte to
have a within-run precision CV greater than _+5%,
however, that was at a concentration level of 1.4 mmol/l.
At the same concentration for BUN, the between-run
precision had the highest CV at + 11"3%. Bicarbonate
was found to have a between-run CV of +8"0/at a level
of 10 mmol/1.
Carry-over
Sample to sample carry-over was 0"49%.
Linearity
All but two of the analytes, BUN and total protein, met
the manufacturer’s stated range of linearity (table 3).
BUN was linear to 32" mmol/1 versus the stated value of
35"7 mmol/1 and the total protein was linear to 80"0 g/1
(stated linearity 140.0 g;/1), but the study was limited by
the lack of material at a higher protein concentration.
Correlation
For each analyte, 74 to 128 serum samples which had
been analysed on SMAC I were run on the Demand with
the exception ofcholesterol where 36 serum samples were
correlated. The original cholesterol correlation had
included 90 samples but the study had to be repeated
upon notification from the manufacturer that the original
assigned calibrator value was changed from 4"0 mmol/1 to
4"4 mmol/1. The range of slope values was 0"9228 to
1.0844 with the exception of lower slope values for ALP,
ALT, and LD. Table 4 lists the range of concentrations
the actual number ofsamples tested for each analyte and
the linear regression equations obtained.
Interference studies
Interference caused by bilirubin concentrations greater
than 171"0 [mol/1 significantly increased bicarbonate
values and decreased creatinine, phosphorus and choles-
terol values. Samples with slight hemolysis (approxi-
mately 500"0 g/l) had significantly increased potassium
and LD, and decreased phosphorus; whereas moderate
hemolysis (approximately 2500"0 g/l) significantly
increased potassium, AST, and CK. Excessive increases
for bicarbonate, LD, and total protein and decreases for
phosphorus and albumin caused by moderate hemolysis.
rendered those samples unsuitable for analysis.
Slight lipemia resulted in significant increases in glucose,
total protein, and phosphorus. Moderate to gross lipemia
increased glucose, total protein, phosphorus, total biliru-
bin and conjugated bilirubin. Any trace of lipemia
increased uric acid concentrations so greatly that the
analysis was deemed unacceptable until the method was
modified by sample blanking and adjustment of the
secondary wavelength from 600 nm to 660 nrn. Moderate
to gross lipemia significantly decreased the concentration
of sodium, potassium, chloride, bicarbonate, creati-
nine, BUN, albumin, ALP, AST, ALT, LD, and CK.
Ultracentrifugation eliminated the lipemia interference
but would not be appropriate for samples to be tested for
total bilirubin and conjugated bilirubin, cholesterol, and
triglyceride. Interferences from hemolysis, bilirubin, and
lipemia with the Demand have recently been reported by
Glick et al. [6].
Discussion
Essentially, the Demand has several valuable technical
features which include flexibility in the choice of test
selection, methods, and source ofreagents. Other features
include sample and reagent metering systems regulated
by a digitally controlled stepping motor. Also, there is
negligible sample-to-sample or reagent-to-reagent carry-
over. Further, the Demand uses small reagent vials
requiring minimal refrigerated storage space, and a
refrigerated turntable is included in the analyser console.
Other useful characteristics include liquid-level detectors
for both samples and reagents, built-in temperature
control and alarms, little day-to-day maintenance, and
no requirement for external plumbing. A diagnostic
program is included in the software which helps in
trouble-shooting and correction of malfunctions.
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Table 2. Precision ofthe Olympus Demand.
Level
Test Mean SD
Within-run
Level 2
CV% Mean SD
All levels N 20
Level 3
CV% Mean SD CV%
Sodium mmol/1 98"8 0.77
Potassium mmol/1 2"2 0"04
Chloride mmol/l 79"9 0"94
Bicarbonate mmol/1 9-9 0"31
Glucose mmol/l 2"4 0.03
Creatinine mol/1 80"4 2"21
BUN mmol/1 1.5 0"08
Total
Protein g/1 45"6 "20
Albumin g/1 20"3 0"50
Inorganic
Phosphorus mmol/1 1.4 0.03
Total
Bilirubin tmol/1 15"6 0"51
Conjugated
Bilirubin mol/1 170"8 1"54
ALP U/I 90"8 2"20
AST U/1 27"0 0"86
ALT U/1 22"2 0"84
LD U/I 143"4 2"91
CK U/1 105"4 1"57
Cholesterol mmol/1 4.1 0.10
Triglyceride mmol/l 1.1 0.04
Uric acid mol/1 279"0 7" 14
0"78 124"1
"88 5"0
1"17 97"1
3"10 20"3
1"29 5"8
2"48 429"0
5"52 5"1
2"51 79"1
2"32 41"7
2"18 2"4
3"39 86"7
0"92
2"32 242"1
3"18 93"1
3"78 79"7
2"03 369"7
1"49 398"7
2"46 6"8
3.43 3"5
2"49 469"9
0"63
0"05
0"81
0"49
0.14
7"10
0.18
"00
0"70
0"03
1"20
4"80
"40
0"82
4"93
2"48
0"12
0"O7
5"95
0"51
0"88
0"83
2"38
2"34
1"52
3"46
1’29
1.55
1"33
1"30
"99
"50
1"02
"24
0"62
1"73
1.93
1"23
147"6
8"0
120"1
30"6
16"7
18"2
258"9
1.24
0"09
1.1
0"6
0.23
0’32
2"22
0"84
"04
0"92
"96
1"38
1.75
0"87
Level
Test Mean SD
Between-run
Level 2
CV% Mean SD
All levels N 20
Level 3
CV% Mean SD CV%
Sodium mmol/1 99"7 1.19 1.20 123"9
Potassium mmol/1 2"3 0"08 3"51 5"
Chloride mmol/1 76" 0"97 1"27 98"8
Bicarbonate mmol/1 10"2 0"82 8"01 19"0
Glucose mmol/1 2"4 0"05 2"08 5"6
Creatinine tmol/1 79"6 0"00 0.00 414"6
BUN mmol/1 1"6 0.19 11"34 5"0
Total
Protein g/l 44"4 1"30 2"83 80"3
Albumin g/1 21"2 0"60 2"78 39"6
Inorganic
Phosphorus g/l 1"3 0"05 3"41 2"5
Total
Bilirubin mol/1 14"9 0"86 5"33 84"8
Conjugated
Bilirubin mol/1 169"8 3"25 1"93
ALP U/1 80"6 3"54 4"39 223"5
AST U/1 25"4 1"26 4"95 89"6
ALT U/1 22"3 1"09 4"86 80"1
LD U/1 135"6 6"27 4"73 374"0
CK U/1 100"3 6"84 6"82 399"7
Cholesterol mmol/l 3"8 0" 12 3"24 6"5
Triglyceride mmol/1 1.1 0"04 3"36 3"3
Uric acid mol/1 276"6 10"71 3"76 472"3
2"21 1.79
0.11 1"79
2"07 2.10
1.27 6"36
0.16 2-92
88.40 2" 12
0"25 5"06
2"30 2"83
1.10 2"62
0"07 2-74
1"20 1’33
6"22 2"79
2"02 2"25
2"00 2"50
9"10 2"43
16"86 4’22
0.16 2"42
0"06 "86
17"25 3"64
147.6 1.64 1.11
8" 0" 16 2"00
120"7 1.70 1.41
30"5 1.75 5"72
16"2 0.09 4.54
18"0 0.54 3"03
258"9 3.08 2"20
After evaluation of the Demand, it was put into routine
operation replacing one SMAC I, providing back up for
the remaining SMAC I, and becoming the primary
instrument for enzyme analysis. The main cost-saving
benefit came from the major decrease in reagent use and
reduction in repeat analysis due to channel malfunctions
ofSMAC I. However, the decrease in technologist time
was not fully realized due to the slow turn-around time for
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urgent measurement of electrolytes and the multiple
technical problems. It has proven, on the whole, to be a
reliable instrument and has held up well with 24 hours a
day, seven days a week useage. Over the last two years the
down time has been minimal (average of 40 hours per
year). This last fact is, in part, attributable to the
diagnostic program included in the instrument’s soft-
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Table 3. Linearity ofthe Olympus Demand.
Test Material
Determined range
oflinearity
Stated range
oflinearity
Sodium
Potassium
Chloride
Bicarbonate
Glucose
Creatinine
BUN
Total protein
Primary aqueous standard
Multi-point linearity standards/scientific products
Primary aqueous standard
Primary aqueous standard
Primary aqueous standard
Multi-point linearity standards/scientific products
Primary aqueous standard
Protein standard solution/Sigma
Chemical Company
Albumin Serum albumin (human) 25%/Cutter Biological
Inorganic Primary aqueous standard
phosphorus
Total Bilirubin/Sigma Chemical Company
bilirubin
Conjugated Pooled patient serum
bilirubin specially prepared albumin based
ALP Material/Clin. Chem. Consultants
AST
ALT
LD
CK
Cholesterol
Triglyceride Patient body fluid with >28"2 mmol/1
oftriglyceride concentration
Uric acid Primary aqueous standard
70-200 mmol/1
1"5-10"0 mmol/1
70-199 mmol/1
0-50 mmol/1
0-41 "6 mmol/1
0-2210 mol/1
0-32"1 mmol/1
0-80"0 g/1
0-60"0 g/1
0-5"2 mmol/1
0"513"0 mol/1
0-205"2 mol/1
0" 1500 U/1
0-600 U/1
0-500 U/1
0-2400 U/1
0-1500 U/1
0-12"9 mmol/1
0-6"8 mmol/1
0-1189"6 lmol/l
80-199
2"5-9"9
70-199
0-50
0-41 "6
0-2210
0-35"7
0-140"0
0-513.0
0-205"2
0-1500
0-600
0-500
0-2400
0-1500
0-12"9
0-6"8
0-1189"6
mmol/l
mmol/1
mmol/1
mmol/1
mmol/1
tmol/1
mmol/1
g/1
g/1
mmol/l
[mol/1
tmol/1
U/1
U/1
U/1
U/1
U/1
mmol/1
mmol/1
tmol/1
Table 4. Correlation ofthe Olympus Demand with SMAC I.
Range of SMAC
Test concentration N mean
Demand
mean Slope Y-intercept
Correlation
coefficient
Sodium 97-178 mmol/1 74 136"7
Potassium 1"2-7"0 mmol/1 124 4"4
Chloride 85-131 mmol/1 94 104"8
Bicarbonate 13-40 mmol/1 85 25"
Glucose 3.8-33" mmol/1 97 8’4
Creatinine 44"2-1785"7 mol/1 128 326’2
BUN 1.8-41.4 mmol/l 120 13"2
Total
Protein 48"0-97"0 g/1 75 69"0
Albumin 15"0-56"0 g/1 78 49"4
Inorganic
phosphorus 5-5-60"4 mmol/1 80 1"3
Total
bilirubin 3"4-451 "4 tmol/1 93 61"6
Conjugated
bilirubin 1"7-256"5 tmol/1 73 20"3
ALP 31-2180 U/1 108 244"2
AST 8-1430 U/1 91 100"8
ALT 6-1550 U/1 89 160"6
LD 107-6640 U/1 100 431"3
CK 15-5140 U/1 77 263"2
Cholesterol 2"3-8"3 mmol/1 36 5"
Triglyceride 0"6-13"6 mmol/1 81 2"5
Uric acid 77"3-868"4 lamol/1 128 328"9
136"2 0"9858 1.43 0.9876
4"4 0.9478 0" 19 0"9946
105.6 0.9915 1.74 0"9528
24"5 0"9228 1"31 0"9571
8"5 1.0114 0.04 0"9991
312" 0"9415 4"60 0"9984
13"0 0.9791 0"27 0"9973
70"3 1"0229 0"30 0"9857
44.4 0.9378 6"00 0"9705
1"4 1.0082 0"06 0"9850
63"3 1.0770 2"57 0.9956
19"4 0.9045 1"20 0.9804
168’4 0"5935 23"51 0"9901
78"9 0.9604 17"95 0"9829
104.1 0"7059 9.33 0.9974
348"8 0.8494 17"50 0"9964
283"0 1"0197 13"56 0"9961
5.4 1.0844 0" 11 0"9949
2’7 1"0384 0" 19 0"9956
331"3 0"9555 17"25 0"9827
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The bilirubin interference with bicarbonate and creati-
nine measurements has remained a major technical
problem for which neither we nor the manufacturer has
been able to provide a satisfactory solution. Samples with
bilirubin levels greater than 171 tmol/1 must be analysed
on another instrument to obtain accurate results for
bicarbonate and creatinine. In addition, bilirubin,
hemolysis, and lipemia interfered at such significant
levels with inorganic phosphorus and uric acid measure-
ments that it was necessary to modify the original
methods with sample blanking and changing of the
secondary wavelength.
Electrolyte measurements on Demand have become a
major area of concern for the authors’ laboratory.
Although the initial evaluation of the sodium, potassium,
and chloride appeared acceptable, it has become appar-
ent that the electrodes are not stable and require
considerable trouble-shooting to correct drift. Of the
three electrodes, the chloride electrode is the most
unstable"leading to anion gap calculation problems and
repeat analysis of the sample. In addition, interferences
due to unidentifiable substances result in values 10 to 15
mmol/1 higher for chloride measurements indicated by
inappropriate anion gap calculations and confirmed by
repeat analysis on other instruments. Further, the routine
weekly maintenance for the ISE module requires to 1"5
h during which the instrument cannot be used for any
analyses. A third problem is the slow turn-around time
for urgent measurements caused by the need for recalib-
ration of sodium, potassium, and chloride electrodes and
the time that is required for the sample to reach the ISE
module. Even by using the priority stat sampler cup (P
cup) mechanism, the most rapid way to run any
particular analysis, it takes 9"5 to 13.5 min from the
beginning to the results being printed (this does not
include the programming time). Finally, the bicarbonate
test must be recalibrated every 4 h due to decreases in
absorbance of the reagents once hydrated and placed in
the instrument. This problem has led to falsely elevated
levels of bicarbonate.
A problem encountered during this assessment was
technical support for the Demand was less than the
industry average. There was not a 24 hours a day, seven
days a week ’hotline’. In addition, there was a lack of
qualified service engineers and great difficulty in obtain-
ing certain key replacement parts. Recently, Olympus
Corporation (Lake Success, New York 11042, USA) has
taken over full responsibility for service.
Our evaluation of the Demand found it to be precise, the
linearities met the stated ranges except forBUN and total
protein, and correlation of the 20 analytes was acceptable
except for the triglyceride method which also measured
free glycerol and was omitted from our test menu. It
became the primary instrument of enzyme analysis
because the increased linearity and good precision
eliminated the large number of repeat analyses required
by the SMAC I. The Demand is easy to operate; does not
require a great deal of personnel training for the basic
operation; and daily and weekly maintenance is minimal
except for the ISE module. Calibration once per 24 h
proved to be valid except for bicarbonate. The three
major disadvantages of the Demand are the bilirubin
interference with serum bicarbonate and creatinine
measurements, slow turnaround time for urgent measure-
ments ofelectrolytes, and the less than adequate technical
support.
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